Marvin Hausman

Marvin Hausman

Chief Executive Officer bei LUDWIG ENTERPRISES, INC.

Vermögen: 29 $ am 31.12.2021

82 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Marvin S.
Hausman
was the founder of Axonyx, Inc. (founded in 1997), where he served as Chairman, President & Chief Executive Officer until 2006.
He was also the founder of Entia Biosciences, Inc. (founded in 2007), where he held the titles of Chairman, CFO, CTO & Chief Scientific Officer in 2015.
Additionally, Dr. Hausman founded Northwest Medical Research Partners, Inc. in 1995 and currently serves as President.
Dr. Hausman is also the founder of King Pharmaceuticals Research & Development, Inc. (founded in [YEAR]).
Dr. Hausman's current job(s) include being the CEO, Chief Science Officer & Director at Ludwig Enterprises, Inc. since 2023, Chairman & Chief Executive Officer at Total Nutraceutical Solutions, Inc. since 2008, Chairman at Pilz Biosciences Corp., and Independent Director at NuGenerex Immuno-Oncology, Inc.Dr. Hausman's former job(s) include being the Chairman, President & Chief Executive Officer at GT Biopharma, Inc. from 2004 to 2008, Chairman & Chief Executive Officer at W World Corp., Director at GT Biopharma, Inc. in 2002 and 2003, Director at Regent Assisted Living, Inc. from 1996 to 2001, Director at Arbios Systems, Inc., Director at Arbios Technologies, Inc. from 2003 to 2005, and Director at TorreyPines Therapeutics, Inc. from 1996 to 2007.
He was also a Member of the American Medical Association, Member-Governors Board at New York University from 1992 to 1998, Research Associate at the National Institutes of Health, and a Member of various scientific and medical associations.
Dr. Hausman's education includes an undergraduate degree from Brooklyn College in 1963 and a doctorate degree from New York University School of Medicine in 1967.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
08.05.2017 14 625 ( 9,72% ) 29 $ 31.12.2021

Aktive Positionen von Marvin Hausman

UnternehmenPositionBeginn
NUGENEREX IMMUNO-ONCOLOGY, INC. Director/Board Member -
LUDWIG ENTERPRISES, INC. Chief Executive Officer 16.11.2023
Chairman -
Chief Executive Officer 01.10.2008
Northwest Medical Research Partners, Inc. Founder 01.10.1995
Alle aktiven Positionen von Marvin Hausman

Ehemalige bekannte Positionen von Marvin Hausman

UnternehmenPositionEnde
IOVANCE BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 26.09.2013
GT BIOPHARMA, INC. Director of Finance/CFO -
Director/Board Member 23.05.2007
Chief Executive Officer 06.10.2006
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Marvin Hausman im Detail an

Ausbildung von Marvin Hausman

Brooklyn College Undergraduate Degree
New York University School of Medicine Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Marvin Hausman im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

30

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
GT BIOPHARMA, INC.

Health Technology

W WORL

Health Technology

ENTIA BIOSCIENCES, INC.

Health Technology

LUDWIG ENTERPRISES, INC.

Finance

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

Private Unternehmen21
King Pharmaceuticals Research & Development, Inc.

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Government

Health Technology

Commercial Services

Commercial Services

Commercial Services

American Federation for Medical Research

The American Association of Immunologists

Northwest Medical Research Partners, Inc.

Commercial Services

Commercial Services

American Board of Urology

Association for Academic Surgery

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Marvin Hausman